Citation: R. Altman et al., Secondary prevent-ion of myocardial infarction, beneficial effect of combining oral anticoagulant plus aspirin - Therapy based on evidence, CL APPL T-H, 6(3), 2000, pp. 126-134
Authors:
Altman, R
Scazziota, A
Rouvier, J
Gonzalez, C
Citation: R. Altman et al., Effect of sodium arachidonate on thrombin generation through platelet activation - Inhibitory effect of aspirin, THROMB HAEM, 84(6), 2000, pp. 1109-1112
Authors:
Gurfinkel, EP
Altman, R
Scazziota, A
Heguilen, R
Mautner, B
Citation: Ep. Gurfinkel et al., Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronarysyndromes, CLIN CARD, 23(9), 2000, pp. 697-700
Authors:
Scazziota, A
Altman, R
Rouvier, J
Gonzalez, C
Ahmed, Z
Jeske, WP
Walenga, JM
Fareed, J
Citation: A. Scazziota et al., Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression, THROMB RES, 100(6), 2000, pp. 479-488
Authors:
Altman, R
Scazziota, A
Rouvier, J
Gonzalez, C
Citation: R. Altman et al., Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregationand ATP release in normal volunteers: Why aspirin improves ticlopidine antiplatelet activity, CL APPL T-H, 5(4), 1999, pp. 243-246
Authors:
Altman, R
Rouvier, J
Scazziota, A
Absi, RS
Gonzalez, C
Citation: R. Altman et al., Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease, CLIN CARD, 22(2), 1999, pp. 85-90
Citation: R. Altman et al., Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor, HAEMOSTASIS, 28(5), 1998, pp. 229-235